Nishan de Silva
2013
In 2013, Nishan de Silva earned a total compensation of $1.1M as Former VP, Finance and Strategy and Chief Financial Officer at Ligand Pharmaceuticals, a 16% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $94,267 |
|---|---|
| Option Awards | $624,065 |
| Salary | $294,583 |
| Stock Awards | $109,600 |
| Other | $2,616 |
| Total | $1,125,131 |
de Silva received $624.1K in option awards, accounting for 55% of the total pay in 2013.
de Silva also received $94.3K in non-equity incentive plan, $294.6K in salary, $109.6K in stock awards and $2.6K in other compensation.
Rankings
In 2013, Nishan de Silva's compensation ranked 6,095th out of 12,286 executives tracked by ExecPay. In other words, de Silva earned more than 50.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,095 out of 12,286 | 50th |
Division Manufacturing | 2,125 out of 4,612 | 54th |
Major group Chemicals And Allied Products | 630 out of 1,466 | 57th |
Industry group Drugs | 454 out of 1,160 | 61st |
Industry Pharmaceutical Preparations | 364 out of 890 | 59th |
Source: SEC filing on April 12, 2016.
de Silva's colleagues
We found four more compensation records of executives who worked with Nishan de Silva at Ligand Pharmaceuticals in 2013.